ZNF511-PRAP1 readthrough (ZNF511-PRAP1)

ZNF511-PRAP1 readthrough is a **naturally occurring readthrough gene product** that arises from transcription between the adjacent ZNF511 (zinc finger protein 511) and PRAP1 (proline-rich acidic protein 1) genes on human chromosome 10[2]. The readthrough transcript encodes a putative fusion protein that appears to play a role in the recognition and inactivation of exogenous plasmid DNA introduced into cells. Specifically, ZNF511-PRAP1 is induced following transfection with plasmid DNA and acts to suppress transcription of these plasmids, distinguishing between exogenous (non-integrated) and endogenous (integrated) DNA. This suppression can result from the formation of a repressor complex with HDAC2, influencing the expression efficiency of nonviral gene delivery systems[1]. The protein is predominantly localized to nuclear bodies, the nucleoplasm, and vesicles within the cell[6]. There are currently no reports indicating that ZNF511-PRAP1 is a validated or recognized therapeutic target, nor are there any known drugs or biomarkers directly associated with it. Its main scientific relevance is in the context of molecular biology and gene therapy research as a barrier to transgene expression, rather than as a conventional drug target or disease-associated protein[1][2].

Other names

ZNF511-PRAP1 readthroughZNF511-PRAP1